A medical expert reveals why the heart, our tireless organ, is remarkably resistant to cancer. Unlike rapidly dividing cells ...
The 2025 Light The Night Executive Challenge raised $10.6 million for Blood Cancer United. Meet three leaders who stepped up.
LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus ...
COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will announce the ...
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...
Patients with HS are at an elevated risk for overall and subtype-specific cancers when compared with the general population without HS.
After doctors dismissed their symptoms, three young women of color found each other online and are now turning their cancer ...
This chart illustrates the trends in ASIR and ASMR of major hematological malignancies, including HL, NHL, MM, and leukemia, across the world, China, and the United States from 1990 to 2021. Based on ...
Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts
Pacific Peoples' Experiences of Cancer and Its Treatment in Aotearoa New Zealand Through Talanoa: A Qualitative Study of Samoan and Tongan Participants We analyzed 2022 Global Cancer Observatory data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results